outlook cgm still compel pt
top pick follow solid oper
margin outlook think beatabl price target move
base higher revenu forecast higher multipl
account potenti margin upsid
bcm host manag dinner attd confer
madrid spain februari pleas contact salesperson
revenu slightli januari preliminari result ep beat
sale slightli manag
pre-announce profit beat above-consensu forecast
think model updat commentari around
expens given present januari pleas see exhibit
pg
new forecast high end manag guidanc
also factor slightli higher price
headwind vs prior revenu assumpt
 increas price headwind lead slightli lower gross
margin line compani outlook oper
margin line manag guidanc howev
compani see faster payback direct-to-consum spend
meaning step think could increment margin
fall vs forecast pleas see exhibit pg summari
estim chang
price target base ev/sal appli higher
think premium justifi given revenu
profit upsid think materi long-term
penetr prospect cgm technolog
extend discuss dxcm posit competit
landscap recent check pleas see june diabet primer
note extend discuss profit ramp prospect
convict compani margin expans stori pleas
see note walk rev/profit per patient assumpt
chang made note
buy chang
page analyst certif
perform rel
inc design commerci
platform use peopl
profit loss summari
growth margin
continu glucos monitor cgm devic use
diabet patient monitor glycem level view
compani technolog best-in-class type platform vs
competit offer abbott
manag work secur greater patient access
pharmaci channel believ price
differenti cgm self-monitor blood glucos test
smbg use finger stick draw blood test blood sugar
set narrow potenti drive greater adopt
 see pathway mid-teen oper margin
bit ahead target manag provid
dec analyst day entri new channel mix shift
pharmaci dme ramp penetr medicar
market creat volum opportun help off-set asp
price target base ev/revenu
sale growth significantli high-growth
med-tech believ deserv premium multipl vs peer
note sale estim includ contribut
pipelin verili addit end-market japan
chang net debt
average cost debt
risk invest thesi
thesi price target could risk compani unabl
drive adopt cgm technolog level
could occur diabet patient clinician believ
technolog better easier use compani unabl
drive sensor price level make afford
addit manag unabl drive leverag profit
forecast could risk
exhibit varianc estim
varianc estim
varianc estim
varianc estim
varianc estim
estimate
estimate
estimate
estimate
inc revenue servic freight accessori etc
sale
sale
expect deliv meaning upsid growth
model high teen patient captur type diabet
market market opportun meaning contempl
forecast partnership livongo health nr announc jan
might help drive penetr longer term much larger arena given upsid
potenti believ stock deserv valu wider ev/sal multipl
premium vs peer pt prior assum prior multipl
sale compar peer prior comp set median revenu
growth rate includ nr nr
compani nr buy could
upsid number compani begin commerci verili
type non-intens insulin initi current factor revenu
model
thesi price target could risk compani unabl drive adopt
cgm technolog level model could occur diabet patient
clinician believ technolog better easier use compani
unabl drive sensor price level make afford widespread
adopt addit manag unabl drive leverag profit
forecast could risk
profit loss account
sale
incom oper
incom oper
incom oper
incom oper
incom equiti invest
net incom provis incom tax
provis incom tax
incom oper
incom oper
incom oper
incom oper
sharecount dilut q/q quarter y/i annual
cash equival
short-term market securit avail sale
prepaid current asset
properti plant equip net
current portion long-term debt
account payabl accru liabil
accru payrol relat expens
current portion defer revenu
oper leas liabil net current portion
prefer stock par share author none issu outstand
treasuri stock cost
total liabil stockhold equiti
total liabil stockhold equiti
total liabil stockhold equiti
total liabil stockhold equiti
oper
oper
oper
oper
depreci amort
non-cash issuanc common stock
impair intang asset
chang asset liabil net effect acquisit
prepaid expens asset
oper leas right use asset liabil
account payabl accru liabil
accru payrol relat expens
defer rent liabil
total chang work capit
net cash oper
net cash oper
net cash oper
net cash oper
invest
invest
invest
invest
purchas market secur
proce matur market secur
purchas equiti invest
purchas pp
acquisit net cash acquir
net cash invest
net cash invest
net cash invest
net cash invest
financ
financ
financ
financ
net proce issuanc common stock
repurchas treasuri stock
payment acquisit relat conting consider liabil
proce issuanc convert debt net issuanc cost
proce sale warrant
purchas convert note hedg
proce short-term borrow
repay short-term borrow
repay long-term debt
net cash financ
net cash financ
net cash financ
net cash financ
net chang cash equival
net chang cash equival
net chang cash equival
net chang cash equival
 begin period
 end period
